What is Noonan Syndrome?

Noonan syndrome is a common autosomal dominant multiple congenital anomaly syndrome that was initially described over 40 years ago.

Image Credit: David Carillet / Shutterstock.com

This disease belongs to the group of RASopathies, which are developmental disorders caused by germline mutations in genes encoding particular proteins of the RAS/mitogen-activated protein kinase (MAPK) pathway.

Genetics and features of Noonan syndrome

The majority of cases of Noonan syndrome stem from mutations in three genes including PTPN11, SOS1, or RAF1. PTPN11 gene mutations account for half of all cases of Noonan syndrome, whereas SOS1 and RAF1 gene mutations account for 10% and 5 to 10% of Noonan syndrome cases, respectively. In 20% of people with Noonan syndrome, the exact cause of the disorder is still unknown.

Despite the lack of stringent diagnostic criteria, the principal features of Noonan syndrome are well established. These include short stature, congenital heart defects, unusual chest shape with pectus carinatum and pectus excavatum, broad or webbed neck, variable degree of developmental delay, cryptorchidism (undescended testes), and characteristic facial features.

Epidemiology

The incidence of Noonan syndrome is consistent and reported to be between 1 in 1,000 and 1 in 2,500 live births, albeit mild expression is said to occur in up to 1 in 100 births in the general population. The characteristic variable expressivity makes it difficult to identify individuals who are only slightly affected.

Familial reappearance is consistent with an autosomal dominant mode of inheritance; however, de novo mutations are more common, accounting for 60% of all cases. In the absence of serious congenital heart defects, there is no reduction in life expectancy. Higher mortality is described in patients with cardiomyopathy.

Researchers have found that among 1,016 children with different congenital heart defects, 1.4% of them had Noonan syndrome. The same has been shown for 7% of children requiring surgery for pulmonary stenosis. There is no known racial predilection for this disorder, and the average age of diagnosis is 9.

Noonan Syndrome

Disease management

Physical and intellectual abilities tend to be normal in most adults with Noonan syndrome, although some of them necessitate multidisciplinary evaluation and regular follow-up care. Management guidelines were recently developed by American and European consortia, and optimized according to age with an emphasis on screening and testing for common health issues.

Treatment of the complications of Noonan syndrome is generally standard and does not differ from treatment in the general population. Infant stimulation programs are available for children with developmental delays. If growth hormone levels are insufficient, growth hormone therapy can represent a viable treatment option. Aspirin therapy should be avoided because it may aggravate a bleeding diathesis.

Extensive variability in the phenotypic expression of Noonan syndrome with a myriad of unresolved questions is a common issue encountered by physicians. The phenotype can vary from mild facial features and minimal pulmonary valve stenosis in adults to severe dysmorphisms with life-threatening heart disease in neonates. Therefore, treatment should be based on the type and severity of the symptoms and complications.

References

Further Reading

Last Updated: Mar 23, 2021

Dr. Tomislav Meštrović

Written by

Dr. Tomislav Meštrović

Dr. Tomislav Meštrović is a medical doctor (MD) with a Ph.D. in biomedical and health sciences, specialist in the field of clinical microbiology, and an Assistant Professor at Croatia's youngest university - University North. In addition to his interest in clinical, research and lecturing activities, his immense passion for medical writing and scientific communication goes back to his student days. He enjoys contributing back to the community. In his spare time, Tomislav is a movie buff and an avid traveler.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Meštrović, Tomislav. (2021, March 23). What is Noonan Syndrome?. News-Medical. Retrieved on April 23, 2021 from https://www.news-medical.net/health/What-is-Noonan-Syndrome.aspx.

  • MLA

    Meštrović, Tomislav. "What is Noonan Syndrome?". News-Medical. 23 April 2021. <https://www.news-medical.net/health/What-is-Noonan-Syndrome.aspx>.

  • Chicago

    Meštrović, Tomislav. "What is Noonan Syndrome?". News-Medical. https://www.news-medical.net/health/What-is-Noonan-Syndrome.aspx. (accessed April 23, 2021).

  • Harvard

    Meštrović, Tomislav. 2021. What is Noonan Syndrome?. News-Medical, viewed 23 April 2021, https://www.news-medical.net/health/What-is-Noonan-Syndrome.aspx.

Comments

  1. Emilce Iara Emilce Iara Argentina says:

    me gustaria poder ver  todo la informacion en español ya que tengo una hija que sufre esta sindrome

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.